Zobrazeno 1 - 2
of 2
pro vyhledávání: '"R. D. Hoy"'
Autor:
C. Mack, David G. Marrero, Hani M. Babiker, S. Ramakumar, Rachit Kumar, T. E. Smith, H. H. Chow, R. D. Hoy, Chiu Hsieh Hsu, P. A. Jones, J. N. Lopez, G. Niemiro, Kerry S. Courneya, Ivo Abraham, Amit M. Algotar, Cynthia A. Thomson, Jennifer A. Ligibel, Shona T. Dougherty
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:903-909
Androgen deprivation therapy (ADT) for prostate cancer is associated with adverse effects, such as obesity and metabolic syndrome, which increase cardiovascular risk, the most common cause of non-cancer mortality in men diagnosed with prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::360187a5c200df74c770ef3ff9dabe36
https://doi.org/10.1038/s41391-021-00346-z
https://doi.org/10.1038/s41391-021-00346-z
Autor:
A M, Algotar, C H, Hsu, H-H, Chow, S T, Dougherty, H M, Babiker, D G, Marrero, I, Abraham, R, Kumar, J A, Ligibel, K S, Courneya, T E, Smith, P A, Jones, J N, Lopez, G, Niemiro, S, Ramakumar, R D, Hoy, C, Mack, C A, Thomson
Publikováno v:
Prostate cancer and prostatic diseases. 24(3)
Androgen deprivation therapy (ADT) for prostate cancer is associated with adverse effects, such as obesity and metabolic syndrome, which increase cardiovascular risk, the most common cause of non-cancer mortality in men diagnosed with prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0493cd962650e3ab6facdc16f837c90e
https://pubmed.ncbi.nlm.nih.gov/33767355
https://pubmed.ncbi.nlm.nih.gov/33767355